ECM
BLFS icon

Everence Capital Management’s BioLife Solutions BLFS Stock Holding History

Everence Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,770
Closed -$395K – 845
2024
Q3 		$395K Hold
15,770
– – 0.02% 494
2024
Q2 		$277 Hold
15,770
– – 0.02% 558
2024
Q1 		$293 Hold
15,770
– – 0.02% 567
2023
Q4 		$256K Hold
15,770
– – 0.02% 610
2023
Q3 		$218 Buy
+15,770
New +$249K 0.02% 636
2022
Q1 		– Sell
-7,260
Closed -$271K – 738
2021
Q4 		$271K Buy
+7,260
New +$312K 0.02% 625

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Everence Capital Management's BLFS Position: Q4 2024 in Review

Everence Capital Management sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 15,770 shares — an estimated $395K sold.

Everence Capital Management first reported a position in BLFS in Q4 2021 and held it in 6 quarters. The position peaked at $395K in Q3 2024. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • Everence Capital Management reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 15,770 BioLife Solutions shares in Q4 2024, an estimated $395K.
  • Everence Capital Management first reported a position in BioLife Solutions in Q4 2021 and held it in 6 quarters.
  • Everence Capital Management's BioLife Solutions position peaked at $395K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.